Revenue

9 Months Ended

Sep. 30, 2021

Revenue [Abstract]

REVENUE

14. REVENUE

We primarily offer the First Defense^Ò product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the three-month periods ended September 30, 2021 or 2020 or during the nine-month periods ended September 30, 2021 or 2020. We do not have any contract assets for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our balance sheets are from contracts with customers. We incur no material costs to obtain contracts.

The following table presents our product sales disaggregated by geographic area:

	During the Three-Month Periods Ended September 30,										During the Nine-Month Periods Ended September 30,
	2021		%			2020		%			2021		%			2020		%
United States	$	4,550,343		88	%	$	3,361,820		90	%	$	12,161,097		88	%	$	10,319,232		89	%
Other		599,830		12	%		360,697		10	%		1,638,032		12	%		1,279,626		11	%
Total Product Sales	$	5,150,173		100	%	$	3,722,517		100	%	$	13,799,129		100	%	$	11,598,858		100	%

The following table presents our product sales disaggregated by major product category:

	During the Three-Month Periods Ended September 30,										During the Nine-Month Periods Ended September 30,
	2021		%			2020		%			2021		%			2020		%
First Defense® product line	$	5,033,428		98	%	$	3,656,709		98	%	$	13,529,847		98	%	$	11,406,481		98	%
Other animal health		116,745		2	%		65,808		2	%		269,282		2	%		192,377		2	%
Total Product Sales	$	5,150,173		100	%	$	3,722,517		100	%	$	13,799,129		100	%	$	11,598,858		100	%